Total Payments
$11,882
2024 Payments
$1,480
Companies
51
Transactions
512
Medicare Patients
1,840
Medicare Billing
$227,835
Payment Breakdown by Category
Food & Beverage$9,838 (82.8%)
Consulting$1,050 (8.8%)
Education$756.23 (6.4%)
Travel$238.26 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,838 | 501 | 82.8% |
| Consulting Fee | $1,050 | 1 | 8.8% |
| Education | $756.23 | 8 | 6.4% |
| Travel and Lodging | $238.26 | 2 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $1,517 | 17 | $0 (2024) |
| ABBVIE INC. | $1,198 | 100 | $0 (2024) |
| GENZYME CORPORATION | $982.59 | 19 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $840.37 | 17 | $0 (2024) |
| LivaNova USA, Inc. | $636.48 | 11 | $0 (2024) |
| Biogen, Inc. | $613.74 | 35 | $0 (2023) |
| UCB, Inc. | $591.24 | 33 | $0 (2024) |
| SK Life Science, Inc. | $506.92 | 14 | $0 (2024) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $447.31 | 38 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $359.50 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,480 | 19 | Alexion Pharmaceuticals, Inc. ($500.00) |
| 2023 | $2,900 | 148 | ABBVIE INC. ($326.97) |
| 2022 | $3,257 | 165 | ABBVIE INC. ($555.09) |
| 2021 | $4,169 | 176 | Genentech USA, Inc. ($1,097) |
| 2018 | $63.25 | 3 | LivaNova USA, Inc. ($63.25) |
| 2017 | $12.87 | 1 | LivaNova USA, Inc. ($12.87) |
All Payment Transactions
512 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $45.23 | General |
| Category: Neurology | ||||||
| 11/07/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $119.60 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 10/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 07/31/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 07/12/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $45.28 | General |
| Category: Neurology | ||||||
| 05/28/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $118.32 | General |
| 05/15/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 05/15/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 05/15/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $97.83 | General |
| Category: EPILEPSY | ||||||
| 05/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $123.63 | General |
| Category: Neurology | ||||||
| 02/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $121.59 | General |
| Category: Neurology | ||||||
| 02/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $144.31 | General |
| 01/19/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Neurology | ||||||
| 01/17/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $85.66 | General |
| Category: Immunology | ||||||
| 01/17/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $13.54 | General |
| 11/15/2023 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $133.38 | General |
| Category: Adenosine A2A Receptors | ||||||
| 10/19/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $17.57 | General |
| 10/19/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Neurology | ||||||
| 10/10/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2023 | Amneal Pharmaceuticals LLC | LYVISPAH (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 447 | 527 | $206,931 | $48,731 |
| 2022 | 5 | 468 | 574 | $235,315 | $57,419 |
| 2021 | 4 | 484 | 650 | $255,095 | $71,429 |
| 2020 | 5 | 441 | 594 | $222,292 | $50,257 |
Total Patients
1,840
Total Services
2,345
Medicare Billing
$227,835
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 220 | 276 | $117,576 | $29,407 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 172 | 196 | $62,328 | $13,625 | 21.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $15,860 | $3,594 | 22.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $8,802 | $1,434 | 16.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $2,365 | $670.56 | 28.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 301 | 394 | $167,844 | $41,607 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 123 | $39,114 | $9,110 | 23.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 31 | 31 | $18,910 | $4,246 | 22.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $7,335 | $1,586 | 21.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 11 | 11 | $2,112 | $870.99 | 41.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 305 | 447 | $190,422 | $53,562 | 28.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 108 | 125 | $39,750 | $10,059 | 25.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 29 | 29 | $17,690 | $4,294 | 24.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 42 | 49 | $7,233 | $3,514 | 48.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 278 | 408 | $173,808 | $38,469 | 22.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 104 | 122 | $38,796 | $7,776 | 20.0% |
| 99358 | Prolonged patient service without direct patient contact first hour | Office | 2020 | 21 | 21 | $4,725 | $1,474 | 31.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 18 | 19 | $2,577 | $1,411 | 54.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 20 | 24 | $2,386 | $1,127 | 47.2% |
About Barbara Bishop, ANPC
Barbara Bishop, ANPC is a Neurology healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588736946.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Barbara Bishop, ANPC has received a total of $11,882 in payments from pharmaceutical and medical device companies, with $1,480 received in 2024. These payments were reported across 512 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($9,838).
As a Medicare-enrolled provider, Bishop has provided services to 1,840 Medicare beneficiaries, totaling 2,345 services with total Medicare billing of $227,835. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Virginia Beach, VA
- Active Since 11/14/2006
- Last Updated 01/22/2008
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1588736946
Products in Payments
- OCREVUS (Biological) $1,155
- ULTOMIRIS (Biological) $810.15
- NURTEC ODT (Drug) $647.29
- UBRELVY (Drug) $569.02
- Briviact (Drug) $516.48
- VNS - Sentiva (Device) $469.85
- QULIPTA (Drug) $430.57
- AUBAGIO (Drug) $418.84
- KESIMPTA (Drug) $386.14
- VALTOCO (Drug) $291.51
- Ocrevus (Biological) $263.58
- TYSABRI (Biological) $254.62
- XCOPRI (Drug) $236.66
- ZEPOSIA (Drug) $235.44
- VUMERITY (Drug) $183.30
- Aimovig (Biological) $174.21
- Nourianz (Drug) $174.13
- AUSTEDO (Drug) $161.99
- ACTHAR (Biological) $152.16
- BOTOX (Biological) $149.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Virginia Beach
Dr. Michelle Betz, Do, DO
Neurology — Payments: $281,749
Neurology $281,749
Dr. Patrick Kilhenny, Md, MD
Neurology — Payments: $130,090
Neurology $130,090
Donald Lamarche, Md, MD
Neurology — Payments: $20,713
Neurology $20,713
Dr. Katharine Heatwole, Md, MD
Neurology — Payments: $8,509
Neurology $8,509
Karen Thomas, Do, DO
Neurology — Payments: $4,348
Neurology $4,348
Dr. Vladimir Ilin, Md, MD
Neurology — Payments: $497.75
Neurology $497.75